A. Nasretdinov

发表

Spectrum and frequency of BRCA1, BRCA2, CHEK2, PALB2, RAD50 mutations in breast cancer patients in the Republic of Bashkortostan

I. Gilyazova, A. Pushkarev, N. Sultanbaeva, 2020 .

Optimal solutions in the third line therapy for refractory metastatic colorectal cancer. CORRECTness and CONCURency

N. Sultanbaeva, A. Nasretdinov, K. Menshikov, 2021, Meditsinskiy sovet = Medical Council.

Neuroendocrine Tumours: a Literature Review

N. Sultanbaeva, A. Nasretdinov, K. Menshikov, 2021, Creative surgery and oncology.

Treatment of advanced small cell lung cancer. Clinical case and literature review

N. Sultanbaeva, A. Nasretdinov, K. Menshikov, 2021 .

Multilineal treatment strategy of HER2-positive metastatic breast cancer (clinical case)

O. Lipatov, D. Sakaeva, A. Pushkarev, 2021 .

Surgical stage in sequential therapy of unresectable oral cancer T3-4bN0-3M0: evaluation of treatment results

A. Nasretdinov, K. Menshikov, S. Musin, 2022, Head and Neck Tumors (HNT).

Experience with olaparib in the treatment of BRCA-associated tumors in real clinical practice. Observational study

O. Lipatov, N. Sultanbaeva, A. Nasretdinov, 2022, Journal of Modern Oncology.

Level of tumor-infiltrating lymphocytes and PD status as potential prognostic markers of survival and therapy effectiveness in triple-negative breast cancer

A. Pushkarev, N. Sultanbaeva, V. Pushkarev, 2020, Tumors of female reproductive system.

Clinical case of the treatment of metastatic luminal breast cancer

N. Sultanbaeva, A. Nasretdinov, K. Menshikov, 2021, Meditsinskiy sovet = Medical Council.

BRCA associated prostate cancer. BRCA heredity of one family

N. Sultanbaeva, A. Nasretdinov, K. Menshikov, 2022, Cancer Urology.

Efficacy and safety of lenvatinib and everolimus combination in patients with metastatic renal cell carcinoma progression following targeted antiangiogenic therapy: secondary analysis of data obtained in the Russian multicenter observational study

A. Antipin, V. Matveev, B. Alekseev, 2021 .

The mechanism of action of different generations of EGFR-inhibitors in malignant lung tumors. Literature review and data synthesis

N. Sultanbaeva, A. Nasretdinov, K. Menshikov, 2022, Journal of Modern Oncology.

Inhibitors of cyclin-dependent kinases 4/6 for breast cancer patients with different somatic mutations of the PIK3CA gene

O. Lipatov, A. Pushkarev, N. Sultanbaeva, 2020, Meditsinskiy sovet = Medical Council.

Oropharyngeal cancer diagnosis and treatment in actual clinical practice in the Republic of Bashkortostan: analysis for 2020

A. Nasretdinov, K. Menshikov, S. Musin, 2023, Creative surgery and oncology.

The role of second-generation EGFR inhibitors in lung cancer therapy in the realities of modern clinical practice

D. Sakaeva, N. Sultanbaeva, A. Nasretdinov, 2021, Onkologiya. Zhurnal imeni P.A.Gertsena.

Breast cancer screening in germline mutation carriers. A literature review

O. Lipatov, N. Sultanbaeva, A. Nasretdinov, 2023, Tumors of female reproductive system.

Possibilities of prevention of nausea during cytostatic therapy: literature review and clinical cases

N. Sultanbaeva, A. Nasretdinov, K. Menshikov, 2023, Meditsinskiy sovet = Medical Council.

Sunitinib in the treatment of advanced renal cell carcinoma

O. Lipatov, N. Sultanbaeva, A. Nasretdinov, 2023, Meditsinskiy sovet = Medical Council.

Experience in treating BRCA-associated breast cancer. The BRCA-history of a family

A. V. Chashchin, A. Nasretdinov, S. Musin, 2021, Meditsinskiy sovet = Medical Council.

The use of ribociclib in real clinical practice: results of a single-center observational retrospective study

N. Sultanbaeva, A. Nasretdinov, K. Menshikov, 2024, Meditsinskiy sovet = Medical Council.

Lenvatinib and pembrolizumab combination in metastatic renal cell carcinoma: experience of the Republic of Bashkortostan

N. Sultanbaeva, A. Nasretdinov, K. Menshikov, 2024, Cancer Urology.

The role of G-CSF in the prevention of cytostaticassociated adverse events during antitumor drug therapy

N. Sultanbaeva, A. Nasretdinov, K. Menshikov, 2024, Meditsinskiy sovet = Medical Council.